US Eye Clinical Studies Page
At US Eye practices nationwide, our Clinical Studies Department stands at the forefront of advancing eye care through rigorous research and innovation. Led by a team of dedicated ophthalmologists and researchers, we are committed to evaluating new treatments and technologies to improve vision and address a wide range of eye conditions. Our collaborative approach to clinical research ensures that patients across our network have access to the latest advancements in eye care. By participating in groundbreaking studies, we strive to elevate the standard of vision care and provide our patients with the most effective treatments available. Experience our commitment to excellence in eye care by visiting any of our US Eye practice locations and joining us on the forefront of clinical innovation.
Ongoing Clinical Trials
ALBEMARLE EYE CENTER
Cataract surgery:
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery (OPTIMIZE-2).
Status: Active, enrolling
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Status: Active, enrollment closed
CENTER FOR SIGHT
Glaucoma:
A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects with Open-Angle Glaucoma or Ocular Hypertension (Denali)
Do you have glaucoma or high eye pressure?
If so, you may qualify for a new investigational eye drop research study!
If you have previously been diagnosed with glaucoma or increased eye pressure and are 18 to 84 years of age, we invite you to participate.
The study involves ~8 office visits over the course of ~ 6 months.
You may be compensated for your time and travel.
Speak with your doctor for more information and to find out if you qualify.
Study location: Center For Sight – Venice. Research@centerforsight.net / 941.480.2158
Status: Active, enrolling
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Ab Externo Implantation of Glaucoma Gel Stent.
Status: Active, enrolling
- Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction with the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension.
HAVE YOU BEEN DIAGNOSED WITH GLAUCOMA?
We are currently conducting a study for people who have been diagnosed with glaucoma or high eye pressure
You may be a possible candidate for this study if you meet the following criteria:
- Male or female, 18 years of age or older
- Are on 0 to 2 ocular hypotensive medications
- No prior incisional glaucoma surgery
The objective of this study is to evaluate the safety and IOP-lowering efficacy of administering an iDose TR (travoprost intraocular implant) in conjunction with the placement of iStent infinite trabecular bypass system compared with placement of iStent infinite trabecular bypass system alone, in subjects with glaucoma or high eye pressure
The expected study duration is approximately 12 months
If you would like more information regarding this study, please contact our research department: Research@centerforsight.net / 941.480.2158
Status: Active, enrolling
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Status: Active, enrollment closed
Cataract Surgery and Intraocular Lenses
Evaluation of the Symfony with Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions.
Presbyopia correcting intraocular lenses (IOLs) are lenses designed to reduce the dependence on glasses after routine cataract surgery. If you have healthy eyes and have been diagnosed with cataracts in both eyes, or, if you are experiencing the symptoms of cataracts including cloudy vision and difficulty driving at night, you may qualify for this study. The study evaluates two already FDA-approved IOLs that could reduce your dependance on glasses.
Compensation is available for qualifying patients. Enrollment is limited.
Medicare & most insurance accepted.
Status: Active, enrolling
Clinical Outcomes of Patients Bilaterally Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL)
Status: Active, enrolling per invitation only
User Acceptability Evaluation of Pesudophakic Patients Previously Implanted with the TECNIS Odyssey IOL.
Status: Active, enrollment closed.
CAROLINA EYECARE PHYSICIANS
Cataract Surgery and Intraocular Lenses:
Evaluation of the Symfony with Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions.
Presbyopia correcting intraocular lenses (IOLs) are lenses designed to reduce the dependence on glasses after routine cataract surgery. If you have healthy eyes and have been diagnosed with cataracts in both eyes, or, if you are experiencing the symptoms of cataracts including cloudy vision and difficulty driving at night, you may qualify for this study. The study evaluates two already FDA-approved IOLs that could reduce your dependance on glasses.
Compensation is available for qualifying patients. Enrollment is limited.
Medicare & most insurance accepted.
Status: Active, enrolling
Evaluation and Clinical Outcomes After Routine Cataract Surgery with the Quatera® 700 and the Centurion® Vision System.
If you have healthy eyes and have been diagnosed with cataracts in both eyes or are experiencing the symptoms of cataracts, including cloudy vision and difficulty driving at night, you may qualify for this study that evaluates two already FDA approved devices used to remove the cataract during surgery.
Compensation is available for qualifying patients. Enrollment is limited.
Medicare & most insurance accepted.
Status: Active, enrolling
RayOne EMV Toric IOL Clinical Study
If your doctor has informed you about the presence of cataracts and astigmatism, there is a
potential opportunity for you to take part in a clinical study focused on the EMV toric intraocular
lens (IOL) implant.
To qualify, you must:
- Be 22 years of age or older
- Have cataracts and astigmatism
- Meet all other study-related criteria
Participants receive:
- Thorough screening evaluation of your eye health
- Follow-up visits for up to 6 months
- Reimbursement for costs related to time and travel
HOW YOU CAN PARTICIPATE
Ask your eye doctor if you are a candidate for the EMV Toric IOL clinical study.
To learn more about the EMV Toric IOL clinical study, please contact the research team at (843) 380 2499
Caution: New Device—Limited by Federal (or United States) law to investigational use
Status: Active, not enrolling
Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00V.
Status: Active, not enrolling
RxSight: RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study.
Status: Active, enrollment closed
Retina:
Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Participants with Diabetic Macular Edema Compared with Intravitreal Ranibizumab (Pagoda)
Status: Active, enrollment closed
Hear From Our Patients
Center For Sight Testimonials:
“I nervously but excitedly accepted an offer to be part of a tear troughs clinical study at Center for Sight supervised by Dr. John Fezza. My tear troughs were very deep and I wanted my eyes to look refreshed, which was achieved. He and his team of highly skilled technicians made the experience not only helpful for my tear troughs to be minimized but also made me actually look forward to my visits. Gina Thomas and Deb, whom I saw every time, made the visits fun and enjoyable. I would recommend anyone who is inclined to entertain the idea of a clinical study with this facility and their professional team, to definitely do so, as I have no regrets and would consider another study with them in the future. Blessed and grateful”
“As a retired nurse I did not have any qualms about participating in Dr Kim’s Glaucoma Study. In fact, I was thrilled to be asked to participate. I have always been a visual learner and recognize that my continued eyesight is a valuable asset for me. I love to watch the birds and am an orchid gardener so being able to contribute to advancements in the treatment of glaucoma and my sight was important to my lifestyle. Dr Kim and his research assistants were pleasant and made being a research subject educational and fun. Thanks to their expertise I am seeing better today!”
“I was in 2 study’s with the Research Department for a total of 6 years. They were very professional, thorough, and also down to earth. I looked forward to going to the appointments as if I was seeing old friends. They answered all the questions I had and offered more answers than I had even thought of. I would not hesitate about doing another research if it was offered to me. Great professional people.”
Carolina Eyecare Testimonials
”I wanted to express my heartfelt gratitude for the kindness and support I received during my participation in the research program. From the dedicated staff to every employee involved, your unwavering kindness and courtesy made a significant impact on me. It truly meant the world to me. I’m beyond thrilled with the results of the program. After relying on thick, unsightly glasses since fourth grade and later switching to contacts at sixteen, I can now see clearly without any aids. It’s a joy to watch my favorite TV shows and read my beloved books with just my pretty little reading glasses. I wish each of you a beautiful day, every day, and may you be blessed abundantly. Thank you for all you do, not just for me, but for all those whose lives you touch through your dedication and hard work.”
“For years, I struggled with poor vision due to severe astigmatism. Wearing glasses became a part of my life at the young age of 8. I attempted to transition to contact lenses but could not get use to them. Then, when Dr. Solomon mentioned the possibility of participating in the research study, it felt like a beacon of hope. This chance to correct both my astigmatism and distance vision during cataract surgery was truly extraordinary, an opportunity I wouldn’t have had otherwise. Since undergoing the surgery, I’ve rediscovered the joy of activities I had reluctantly set aside due to my eyesight. But perhaps the most profound moment came immediately after the surgery when I caught sight of myself in the mirror. For the first time in over sixty years, I saw my face without glasses. It was an astonishing revelation, I never knew, and dare I say it, I realized I’m quite the good-looking fella. I am immensely grateful to Dr. Solomon and his research team who made this possible.”
“Taking part in the LASIK study was a game-changer for me. As a young person navigating the world with glasses, my vision struggles often felt like a barrier to fully experiencing life. I constantly worried about losing or breaking my glasses, or my contacts. When the opportunity came up to participate in the LASIK study, I saw it as a chance to break free from these limitations. The thought of waking up and being able to see clearly without reaching for glasses was incredibly appealing. Since undergoing LASIK as part of the study, my life has changed in ways I couldn’t have imagined. It’s liberating to go about my day without constantly adjusting or worrying about my vision. To anyone considering participating in a LASIK study or any vision research, I say go for it. It’s not just about improving your vision. it’s about reclaiming your freedom and embracing a new way of seeing the world.”
Past Clinical Trials
Albemarle Eye Center
Cataract Surgery
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
Status: Completed
Multicenter Post-Approval Study of The Glaukos® iStent® Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery.
Status: Completed
Nepafenac Once Daily for Macular Edema – Study.
Status: Completed
Post Approval Study of the AcrySof® IQ Toric Intraocular Lens (IOL) Models SN6AT6-SN6AT9.
Status: Completed
Clinical Investigation of the Clareon® Intraocular Lens (IOL).
Status: Completed
Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
Status: Completed
RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery.
Status: Completed
A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To an Experimental Ophthalmic Sterile Ointment Containing Tobramycin and Dexamethasone in Aqueous Humor In Patients Undergoing Indicated Cataract Surgery (TBO).
Status: Completed
Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation.
Status: Completed
Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery.
Status: Completed
Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis (EGP-437-006).
Status: Completed
OCS-01 in Treating Inflammation and Pain in Post-cataract Patients (SKYGGN).
Status: Completed
OCS-01: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
Status: Completed
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects with Dim Light Vision Disturbances.
Status: Completed
Glaucoma
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%.
Status: Completed
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension (Mont Blanc).
Status: Completed
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants with Open-angle Glaucoma or Ocular Hypertension.
Status: Completed
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Status: Completed
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia).
Status: Completed
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty.
Status: Completed
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension.
Status: Completed
Presbyopia
An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1) (NEAR-1).
Status: Completed
An Evaluation of the Safety of CSF-1 in Presbyopic Subjects.
Status: Completed
Center For Sight
Cataract Surgery and Intraocular Lenses
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey IOL
Status: Completed
Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses
Status: Completed
Evaluating the New Synergy IOL – First 7 Months Data From Two US Centers
Status: Completed
Status: Completed
Evaluating a novel strategy: The Synergy IOL mixed & matched with the Symfony w/Intelilight
Status: Completed
Post Approval Study of the Tecnis Symfony® Toric Lenses
Status: Completed
Glaucoma
A phase IV, prospective, 18-month study to assess the effectiveness and safety of
bimatoprost intracameral implant (DURYSTATM) in US clinical practice
Status: Completed
A Multi-Center, Open Label Rocklatan (Netarsudil/Latanoprost Ophthalmic solution) 0.02%/0.005% evaluation of IOP Lowering Efficacy and Safety as Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension
Status: Completed
The Hydrus Microstent for Refractory Open-Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)
Status: Completed
Randomized, Multicenter, Observer-Masked Study to Compare Safety/Efficacy of Nebivolol Suspension 0.5% or 1.0%, or Timolol Suspension 0.5% to Timolol Solution 0.5% in Participants with Primary Open Angle Glaucoma or Ocular Hypertension
Status: Completed
Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant
Status: Completed
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
Status: Completed
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients with Open-Angle Glaucoma or Ocular Hypertension
Status: Completed
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension in a Real-world Setting
Status: Completed
Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients with Glaucoma and Ocular Hypertension
Status: Completed
A Randomized, Double-Masked, Active-Controlled, Parallel Group, Multi-Center Bioequivalence Study of The Generic Brinzolamide 1% Ophthalmic Suspension Compared to Reference Listed Drug Azopt® (Brinzolamide) Ophthalmic Suspension 1% In Subjects With Primary Open Angle Glaucoma Or Ocular Hypertension
Status: Completed
Oculoplastic
Teo-RHA-1902 A Randomized, Blinded Evaluator, No-Treatment Control, Multicenter, Prospective Clinical Study of RHA® 1 For the Treatment Of Moderate To Severe Tissue Volume Deficiencies In The Infraorbital Regions
Status: Completed
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Status: Completed
A Phase 2a, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Efficacy, Safety, and Duration of Benefit of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
Status: Completed
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing.
Status: Completed
A Research Study to See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects with Dry Eye Disease
Status: Completed
Presbyopia
A Multi-Center, Double-Masked Phase 3 Evaluation of the Long-Term Safety of LNZ101
in Presbyopic Subjects.
Status: Completed
Investigation of the Presbia Flexivue Microlens™ Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes.
Status: Completed
Other
Optos P200TE Agreement and Precision Study
Status: Completed
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora.
Status: Completed
Retina
A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration
Status: Completed
Safety and Efficacy of Abicipar Pegol (AGN‐150998) in Patients with Neovascular Age‐Related Macular Degeneration
Status: Completed
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Completed
Ocriplasmin Research to Better Inform Treatment (ORBIT)
Status: Completed
A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Completed
Caroline Eyecare Physicians
Cataract Surgery & Intraocular Lenses
Evaluating A Novel Strategy: The Synergy IOL Mixed and Matched with the Symfony with Intelilight.
Status: Completed
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL.
Status: Completed
Evaluation of Clareon Vivity/Vivity Toric.
Status: Completed
Clareon toric vs Eyhance toric.
Status: Completed
Evaluating the new Synergy IOL – First 3 months data from Two US centers.
Status: Completed
Visual Performance and Patient Satisfaction with A New Monofocal Intraocular Lens.
Status: Completed
Satisfaction and Spectacle Independence Evaluation of the Acrysof® IQ Vivity® Intraocular Lens Targeted for Emmetropia or Nanovision.
Status: Completed
Clinical Comparison of Contrast Sensitivity Measures in the Pseudophakic Population.
Status: Completed
A Prospective Randomized Controlled Multi-Center Clinical Study to Evaluate the Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus
Status: Completed
Evaluation of Angle Kappa and Different Intraocular Lens Calculation Formulas in Acrysof® IQ Panoptix Intraocular Lens Outcomes, Visual Disturbances and Patient Satisfaction.
Status: Completed
Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens (BRAVO).
Status: Completed
Clinical Investigation of the Tecnis Next Generation Intraocular Lenses.
Status: Completed
Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00.
Status: Completed
Post–Approval Study of the Tecnis® TORIC IOL Extended Cylinder Range (ECR), MODELS ZCT450, ZCT525 and ZCT600.
Status: Completed
Postmarket Study of ORA With VerifEye+ and Barrett Toric Calculator Used for the Implantation of AcrySof Toric.
Status: Completed
Optimizing the Assessment of Refractive Outcomes after Cataract Surgery and Implantation of a Monofocal IOL.
Status: Completed
Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Postsurgical Inflammation and Pain.
Status: Completed
A Phase 3, Prospective, Randomized, Open Label, Parallel-design, Multicenter Study to Evaluate the Safety of IBI 10090 for the Treatment of Inflammation Associated with Cataract Surgery.
Status: Completed
Clinical Evaluation of the Lenstec SBL-3™ Intraocular Lens.
Status: Completed
Comparison of Dropless Prophylaxis after Routine Phacoemulsification to Standard Drops Regimen.
Status: Completed
A Multi-Center, Prospective, Randomized, Contralateral Comparison of 1-Month Postoperative Refractive Outcomes between Intraoperative measurements obtained with the Optiwave Refractive Analysis System (ORA System®with VerifEye) Combined with Implantation of an Alcon Toric IOL and standard biometry and Alcon Toric IOL implantation.
Status: Completed
Clinical Outcomes Data Collection of Patients Who Are Undergoing Cataract Surgery with Alcon VERION.
Status: Completed
A Prospective Multi-Center Study to Evaluate Performance of Phacofragmentation with the LenSx laser.
Status: Completed
Intra-operative Metrics and Clinical Outcomes after Cataract Surgery with the Centurion Vision System and the Infiniti Vision System.
Status: Completed
Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Toric Intraocular Lens Model SND1T2.
Status: Completed
A Study Evaluating the Surgical Procedure and Nomograms for Femtosecond Laser Created Arcuate Incisions in The Treatment Of Preexisting Astigmatism In Patients Scheduled To Undergo Monocular Cataract Surgery.
Status: Completed
Evaluation of a Modified Disposable Contact Lens Patient Interface for the LenSx laser in Cataract and Cornea Surgery.
Status: Completed
A Multicenter, Randomized, Controlled Study of the Safety and Effectiveness of ACRYSOF@ IQ ReSTOR@ +8.0 0 Multifocal IOL in Comparison to ACRYSOF IQ Monofocal IOL in Subjects with Age-Related Macular Degeneration and Cataract.
Status: Completed
A Prospective, Randomized, Contralateral, Multi-Center Trial to Evaluate The Safety And Efficacy Of Using The Alcon Lensx Femtosecond Laser In Cataract Surgery Compared To A Manual Group.
Status: Completed
Post Approval Study of the AcrySof® IQ Toric High Cylinder Power Intraocular Lens (IOL) Models SN6AT6-SN6AT9.
Status: Completed
Evaluation of a Modified Disposable Contact Lens Patient Interface for the LenSx laser in Cataract and Cornea Surgery.
Status: Completed
Clinical Investigation of AcrySof® IQ ReSTOR® Multifocal Toric IOL Model SND1T3/ SND1T4/ SND1T5/ SND1T6.
Status: Completed
Evaluation of the LenSx Laser System for Performing Anterior Capsulotomy, Phacofragmentation, and Corneal Arc Cuts/Incisions in Patients Undergoing Cataract Surgery for Removal of the Crystalline Lens.
Status: Completed
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations and Functional Vision Correlation after SN60WF IOL Implantation.
Status: Completed
A Randomized subject-masked comparison of visual function after bilateral implantation of Presbyopia-correcting lenses.
Status: Completed
An Assessment of Residual Spherical Aberration, Postoperative Total High Order Aberrations and Functional Vision Correlation after SN60WF IOL Implantation.
Status: Completed
A Randomized, Masked Multi-center Safety & Efficacy Study of the Effects of Preoperative & Postoperative Cataract Surgery Use of Difluprednate Ophthalmic Emulsion, 0.05% Compared to Prednisolone Acetate Ophthalmic Suspension 1% on Visual Acuity & Corneal Edema.
Status: Completed
Dry Eyes
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery.
Status: Completed
A Prospective Randomized Masked Placebo Controlled Comparative Study to Measure the Effects of Omega-3 Fatty Acid Nutritional Supplementation on the Thickness of the Lipid Layer in Subjects Presenting with Dry Eye Symptoms Due to Meibomian Gland Dysfunction.
Status: Completed
Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye.
Status: Completed
Glaucoma
A Prospective, Randomized, Controlled, Single-Masked, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS Injector System in Conjunction with Cataract Surgery.
Status: Completed
A Phase 2 Study Evaluating Safety and Efficacy of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open Angle Glaucoma (OAG).
Status: Completed
Clinical Investigation of the Glaukos® Trabecular Micro-Bypass Stent Model GTS400 in Conjunction with Cataract Surgery.
Status: Completed
Other
Surgeon Evaluation of the Optiwave® Refractive Analysis System with VerifEye+® (ORA System® with VerifEye+®).
Status: Completed
A Multi-Center, Prospective, Observer Masked, Clinical Evaluation of the Dynamic Reticle in the Optiwave Refractive Analysis System with VerifEye (ORA System® with VerifEye).
Status: Completed
A Multi-Center, Prospective, Evaluation of Images Captured on Aphakic Eyes utilizing an Orange® Optical Head with a Super Luminescent Diode Light Source (SLED).
Status: Completed
A Multi-Center, Prospective Evaluation of Aphakic IOL Power Calculation utilizing the ORange® Intraoperative Wavefront Aberrometer Performed in Eyes Undergoing Cataract Surgery or Refractive Lens Exchange which have undergone Previous LASIK or PRK.
Status: Completed
Refractive Outcomes Evaluation of the VERIONTM Image Guided System + ORA System with VerifEye.
Status: Completed
A Device Evaluation Study to Assess the Physical and Clinical Performance of Prototype Punctal Plug Design Iterations.
Status: Completed
Refractive Surgery
Pivotal Trial of WaveLight® EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes™ in Conjunction with InnovEyes™ sightmap.
Status: Completed
A Clinical Study Evaluating the Safety, Efficacy and Patient Satisfaction In Regards To Visual Outcome In Eyes Where The Horizontal Corneal Flap Is Created With A Femtosecond Laser Using A 6×6 Spot Size Compare With Flaps Created With A 9×9 Spot Size, In Patients Who Are Undergoing A Bilateral Lasik Procedure.
Status: Completed
Visual outcomes and induction of high order aberrations after Myopic Wavefront-guided LASIK.
Status: Completed
Visual Outcomes and Induction of High Order Aberrations After Myopic Guided-Wavefront LASIK.
Status: Completed
A Clinical Study Evaluating the Safety, Efficacy and Patient Satisfaction on Corneal Sensation and Signs & Symptoms of Dry Eye, in Eyes Receiving A 30 Degree Side Cut Compared with Eyes Receiving a 140 Degree Side Cut in Creating the Horizontal Corneal Flap, in Individuals Who Are Undergoing a Bilateral Lasik Procedure.
Status: Completed
Retina
To find out more about clinical study opportunities with US Eye please fill out the form below or contact us by email.
Email: researchstaff@useye.com
Clinical Studies Interest Form
- Follow Us
-
-
